tm logo
ONCONETIX
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

record initialized not assigned to examiner

on 16 Dec 2023

Last Applicant/ Owned by

SUITE 1900

CINCINNATI

OH

45202

Serial Number

98267927 filed on 13th Nov 2023

Registration Number

N/A

Correspondent Address

DANIELLE COHEN, ESQ.

ELLENOFF GROSSMAN & SCHOLE LLP

1345 AVENUE OF THE AMERICAS

FLOOR 11

NEW YORK, NY 10105

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ONCONETIX

Pharmaceuticals; pharmaceuticals, namely, small molecules, biopharmaceuticals, cellular therapies, gene therapies, vaccines, CRISPR-Cas9 derived, CAR T-Cell derived, N - 1 personalized drug therapies, Antibody-Drug-Conjugates (ADCs), Oncolytic viruses, monoclonal antibodies, bi-specific antibodies, virus-like particles-based therapeutics, and nano-encapsulated drug like synthetic therapeutics; diaRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceuticals; pharmaceuticals, namely, small molecules, biopharmaceuticals, cellular therapies, gene therapies, vaccines, CRISPR-Cas9 derived, CAR T-Cell derived, N - 1 personalized drug therapies, Antibody-Drug-Conjugates (ADCs), Oncolytic viruses, monoclonal antibodies, bi-specific antibodies, virus-like particles-based therapeutics, and nano-encapsulated drug like synthetic therapeutics; diagnostics; diagnostics, namely, in-vitro, in-vivo, and cell-based assays, cell culture processes, laboratory-developed tests (LDTs), cell-based imagining, genomics, gene-based expression assays, proteomics, protein-based expression assays, immunohistochemistry (IHC), drug sensitivity and treatment diagnostics, diagnostic algorithms and decision-making computational software to support screening, diagnosing, monitoring and treatment modalities; medical devices; medical devices, namely, devices that deliver therapeutic drugs of various types, namely, small molecules, biopharmaceuticals, cellular therapies, gene therapies, vaccines, CRISPR-Cas9 derived, CAR T-Cell derived, N - 1 personalized drug therapies, Antibody-Drug-Conjugates (ADCs), Oncolytic viruses, monoclonal antibodies, bi-specific antibodies, virus-like particles-based therapeutics, and nano-encapsulated drug like synthetic therapeutics, into the human body utilizing both in-vivo and in-vitro (gene or cellular therapies) methods for personalized medical therapeutics; Computational, Software, and decision systems; computational, software, and decision systems, namely, products and services for clinical and after-regulatory approval of both therapeutics and diagnostics (theranostics) that support and maintain pre-clinical trials, clinical trials and assessments of patient's tumors in their staging and treatment; Biobanking and Research; biobanking and research, namely, acquisition, processing, analysis, and storage of human and animal specimens in a biobanking facility that is used for personalized medicine with patient treatment (therapeutics and diagnostics). Digital Pathology and other imaging and cellular systems for the characterization of human and animal tumors

Mark Details


Serial Number

No 98267927

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 17974.036

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
24th Jan 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
16th Dec 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED